{"id":"NCT00500318","sponsor":"AstraZeneca","briefTitle":"A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 6-Week Clinical Study to Assess the Effect of Inhaled Aclidinium Bromide (LAS34273) 200 ug on Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe COPD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2008-12","completion":"2010-09","firstPosted":"2007-07-12","resultsPosted":"2012-12-17","lastUpdate":"2017-01-06"},"enrollment":181,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"Aclidinium Bromide","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Aclidinium","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study evaluated the effect of inhaled aclidinium bromide on exercise endurance and in reducing resting and dynamic lung hyperinflation in patients with moderate to severe COPD. It was 9 weeks in duration, consisting of; a 2-week run-in period, 6 weeks of double-blind treatment, and a 1-week follow-up phone call. All patients meeting the eligibility criteria were randomized to one of two treatment groups: aclidinium bromide or placebo.","primaryOutcome":{"measure":"Change From Baseline in Exercise Endurance Time (ET)","timeFrame":"From baseline Week 0 (Visit 4) to Week 6 (Visit 6)","effectByArm":[{"arm":"Aclidinium","deltaMin":129.45,"sd":31.19},{"arm":"Placebo","deltaMin":13.01,"sd":30.97}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0042"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":52,"countries":["United States","Canada"]},"refs":{"pmids":["21183326"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":86},"commonTop":["Headache","Chronic Obstructive Pulmonary Disorder","Cough","Upper Respiratory Tract Infection"]}}